Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Crism Thera (CRTX) Share Price

Price 18.50p on 09-05-2025 at 18:05:07
Change -2.50p -11.9%
Buy 21.00p
Sell 16.00p
Buy / Sell CRTX Shares
Last Trade: Unknown 3,158.00 at 18.50p
Day's Volume: 146,224
Last Close: 18.50p
Open: 21.00p
ISIN: VGG042401262
Day's Range 18.50p - 21.00p
52wk Range: 5.25p - 29.00p
Market Capitalisation: £6m
VWAP: 18.124p
Shares in Issue: 33m

Crism Thera (CRTX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 3,158 18.50p Ordinary
15:38:41 - 09-May-25
Sell* 13,442 16.70p Ordinary
15:27:27 - 09-May-25
Buy* 664 19.77p Ordinary
14:52:04 - 09-May-25
Unknown* 55,250 17.10p Ordinary
10:32:43 - 09-May-25
Buy* 2,434 20.33p Ordinary
10:26:11 - 09-May-25
Sell* 254 18.50p Ordinary
10:16:06 - 09-May-25
Sell* 194 18.50p Ordinary
10:14:09 - 09-May-25
Buy* 1,343 20.50p Ordinary
09:36:05 - 09-May-25
Sell* 457 18.33p Ordinary
09:19:40 - 09-May-25
Sell* 25,000 18.33p Ordinary
09:17:19 - 09-May-25
See more Crism Thera trades

Crism Thera (CRTX) Share Price History

Time period:
to
Date Open High Low Close Volume
9th May 2025 (Fri) 21.00 21.00 18.50 18.50 146,224
8th May 2025 (Thu) 18.00 21.00 18.00 21.00 83,864
7th May 2025 (Wed) 14.00 17.50 14.00 17.50 177,656
6th May 2025 (Tue) 20.00 20.00 14.00 14.00 211,499
5th May 2025 (Mon) 21.76 21.76 21.76 21.76 0
2nd May 2025 (Fri) 16.50 29.00 16.50 20.00 888,860
1st May 2025 (Thu) 13.50 16.50 13.50 16.50 120,174
30th Apr 2025 (Wed) 13.00 13.50 13.00 13.50 178,712
29th Apr 2025 (Tue) 10.50 13.50 10.50 13.00 256,380
28th Apr 2025 (Mon) 10.00 10.50 10.00 10.50 132,589
25th Apr 2025 (Fri) 9.50 10.00 9.00 10.00 113,343
24th Apr 2025 (Thu) 9.50 9.50 9.50 9.50 10,250
23rd Apr 2025 (Wed) 9.50 9.50 9.50 9.50 37,500
22nd Apr 2025 (Tue) 9.50 9.50 9.50 9.50 55
21st Apr 2025 (Mon) 9.50 9.50 9.50 9.50 0
18th Apr 2025 (Fri) 9.50 9.50 9.50 9.50 0
17th Apr 2025 (Thu) 9.50 9.50 9.50 9.50 625
16th Apr 2025 (Wed) 9.50 9.50 9.50 9.50 5,900
15th Apr 2025 (Tue) 9.50 9.50 9.50 9.50 6,747
14th Apr 2025 (Mon) 9.50 9.50 9.50 9.50 19,459
11th Apr 2025 (Fri) 9.50 9.50 9.50 9.50 221
10th Apr 2025 (Thu) 9.50 9.50 9.50 9.50 1,165
See more Crism Thera price history

Crism Thera (CRTX) Regulatory News

Date Source Headline
7th Apr 2025 11:46 am RNS Director Dealing
31st Mar 2025 7:00 am RNS Clinical Trial Update
27th Mar 2025 7:00 am RNS Innovate UK Grant Award
20th Dec 2024 7:00 am RNS Appointment of Specialist Clinical CRO
18th Dec 2024 7:00 am RNS European Patent Grant
19th Sep 2024 7:00 am RNS Interim Results
9th Sep 2024 7:00 am RNS Notice of Interim Results & IMC Presentation
2nd Sep 2024 7:00 am RNS Innovation Passport Award
30th Jul 2024 7:00 am RNS CRISM Signs Service Agreement Contract
3rd Jul 2024 4:18 pm RNS Response to Movement in Share Price
See more Crism Thera regulatory news

Crism Thera (CRTX) Share News

IN BRIEF: CRISM Therapeutics gets European patent for tumour therapy

19th Dec 2024 08:32

CRISM Therapeutics Corp - Surrey-headquartered pharmaceutical firm - Granted a European patent for its lead product ChemoSeed by the European Patent Office. This covers the manufacturing process for the preparation of chemotherapeutic drug implants and their use in therapy, particularly in treating brain tumours such as high grade glioma. ChemoSeed facilitates the local delivery of irinotecan directly to the brain tumour resection site, which allows the delivery of larger doses and reduces systemic concentrations. This alleviates traditional side effects for the patient. Read More

UK earnings, trading statements calendar - next 7 days

12th Sep 2024 13:55

Read More

IN BRIEF: Crism flags contract talks, reacts to share price surge

3rd Jul 2024 19:03

Crism Therapeutics Corp - Pharmaceutical company headquartered in Surrey - Notes the increase in the share price on Wednesday, confirms that it is not aware of any specific reason for the increase. Points out the share price has fallen since admission to AIM in May. Continues to work on its stated strategy of submitting a clinical trial application in the second half of 2024 for its lead product, ChemoSeed. Also at contract stage to provide services with an early stage UK small and medium sized enterprise who are seeking to utilise Crism's drug formulation expertise. The value of that contract would be around GBP230,000. Read More

IN BRIEF: Crism has first day of trade on AIM after name change, buy

31st May 2024 21:58

Crism Therapeutics Corp - Pharmaceutical company headquartered in Surrey - Begins first day of trading on AIM. On Wednesday, Crism changed its name from Amur Minerals Corp, after purchasing Extruded Pharmaceuticals Ltd and exiting its mineral exploration business. Read More

See more Crism Thera news
FTSE 100 Latest
Value8,554.80
Change23.19

Login to your account

Forgot Password?

Not Registered